Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

The New England journal of medicine - 23 Dec 2004

Imperiale Thomas F, Ransohoff David F, Itzkowitz Steven H, Turnbull Barry A, Ross Michael E

Abstract excerpt

BACKGROUND: Although fecal occult-blood testing is the only available noninvasive screening method that reduces the risk of death from colorectal cancer, it has limited sensitivity. We compared an approach that identifies abnormal DNA in stool samples with the Hemoccult II fecal occult-blood test in average-risk, asymptomatic persons 50 years of age or older. METHODS: Eligible subjects submitted one stool...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenoma
Share to Area Under Curve

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonoscopy

Share to DNA, Neoplasm

Share to Mass Screening

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 15616205
DOI: 10.1056/NEJMoa033403

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.PMID 15616205Read ↗

Multitarget stool DNA testing for colorectal-cancer screening.Semantic proximity Read ↗

Multitarget Stool DNA Testing for Colorectal-Cancer ScreeningSemantic proximity Read ↗

Colorectal Cancer Screening in Average Risk Patients.Semantic proximity Read ↗

Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panelSemantic proximity Read ↗

High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.Semantic proximity Read ↗

Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.Semantic proximity Read ↗

Detection of the mutated K-Ras biomarker in colorectal carcinoma.Semantic proximity Read ↗

Colorectal cancer screening of high-risk individuals.Semantic proximity Read ↗

The Utility of Multitarget Stool DNA Testing for Colorectal Cancer Screening After a Normal ColonoscopySemantic proximity Read ↗

Performance of multitarget stool DNA testing in African American patientsSemantic proximity Read ↗

Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia.Semantic proximity Read ↗

Colorectal cancer screening in average- and high-risk groups.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.